Skip to content

Clinical trials

Lung Diseases, Interstitial trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Country / region: Belgium Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20173
20193
20204
20212
20226
20237
20243
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting7
Active, not recruiting5
Unknown status4
Enrolling by invitation2
No longer available1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim9
Bristol-Myers Squibb3
Insmed Incorporated3
KU Leuven3
United Therapeutics3
Cliniques universitaires Saint-Luc- Université Catholique de Louvain2
GlaxoSmithKline2
Universitaire Ziekenhuizen KU Leuven2
AstraZeneca1
Avalyn Pharma Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial36
Hypertension, Pulmonary5
Pulmonary Fibrosis5
Scleroderma, Diffuse5
Idiopathic Pulmonary Fibrosis4
Arthritis, Rheumatoid3
Autoimmune Diseases3
Scleroderma, Systemic3
Connective Tissue Diseases2
Fibrosis2

Trials

Showing 26 to 36 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.